Guides

How to Tell If a Scientific Study Is Trustworthy

Last updated June 2026

"A study found…" is the beginning of a question, not the end of one. A single result can be early, narrow, or simply wrong — and learning to ask a few sensible questions of it is one of the most useful reading habits you can develop.

Science works slowly and by accumulation, not by single dramatic discoveries. The version most of us meet has usually passed through several hands first: researchers, a university press office, a wire agency, and finally a headline writer. By the time you read it, the careful "this might suggest" of the original paper can become a confident "this proves". You do not need a science degree to push back on that. You mostly need to know what a strong study looks like and where the weak points tend to hide.

The hierarchy of evidence

Not all studies carry the same weight, and researchers loosely rank them in what is often called a hierarchy of evidence. It is a useful mental ladder, even if real research is messier than any neat diagram.

When you see a striking claim, it is worth asking quietly: where on this ladder does the evidence sit? A claim resting on one small observational study deserves more caution than one backed by a well-conducted review.

Correlation is not causation

This is the single most common trap in how studies are reported. If two things move together — say, people who do X tend to have more of Y — it does not follow that X causes Y. Y might cause X, both might be driven by some third factor, or the link might be coincidence. Observational studies are especially prone to this, because people who choose to do something often differ in many other ways too.

A trustworthy account is careful with its verbs. "Linked to", "associated with" and "correlated with" are honest signals of an observed pattern. "Causes", "triggers" or "leads to" are much stronger claims that usually need a controlled trial to support them. When a headline upgrades a link into a cause, that is a sign to slow down.

Who was studied, and how many?

The size and nature of the sample matter enormously. A finding from a handful of participants is far shakier than one drawn from thousands, because small samples are easily swayed by chance. A small study is not worthless, but it is a first hint, not a verdict.

Humans, mice, or cells in a dish?

Plenty of promising results come from studies in mice or in laboratory cell cultures. These are genuinely valuable for understanding how something works, but a great many findings that look exciting in a mouse never pan out in people. If a "breakthrough" turns out to rest on animal or test-tube work, that is important context that headlines routinely leave out.

Were the right people studied?

It also matters whether the participants resemble the people the claim is being applied to. A result from young, healthy volunteers may not transfer to older people with other conditions, and a study in one country or population may not generalise everywhere. Ask who was in the study before assuming the conclusion is about you.

Peer review and where it was published

Before most reputable research appears in a journal, other independent experts review it and can demand changes or reject it outright. Peer review is not a guarantee of truth — flawed papers still slip through, and good ones are sometimes held back — but it is a meaningful quality filter, and its absence is worth noticing.

Where a study appears is a clue too. Established journals have reputations to protect and editorial standards to match. At the other extreme are so-called predatory journals: outlets that will publish almost anything for a fee, with little or no genuine review. A claim's only home being an obscure pay-to-publish journal is a quiet warning sign. If a result is real and important, it rarely lives in just one questionable place.

Who paid for it?

Funding does not automatically discredit research — much excellent work is funded by industry, charities or governments. But who paid, and what they stood to gain, is legitimate context. A study into a product funded by the company selling that product carries an obvious potential conflict of interest, and reputable journals now require such interests to be declared.

Look for a funding statement and a conflicts-of-interest declaration; good papers include them. The point is not to assume the worst, but to read the results with appropriate care when the people who paid for the study had a clear stake in how it turned out.

Preprints versus published papers

Increasingly, studies appear first as preprints — early versions posted publicly before peer review. Preprints made research faster and more open, but they have not yet been checked by independent experts. They can be wrong, and some that circulate widely are later revised or quietly withdrawn. A preprint is not a scandal; it is just early, and it deserves to be read as a draft rather than a settled finding.

The press-release problem

Much of the distance between a paper and a misleading headline opens up before a journalist is even involved. Universities issue press releases to promote their researchers' work, and those releases sometimes overstate what was actually found. News outlets, under pressure for clicks, may then amplify the boldest line. The result is a chain in which each link rounds up a little, until a tentative finding becomes a confident promise.

The defence is simple: try to get closer to the source. Does the article name the journal and let you find the actual study? Does it mention the study's own limitations, which good papers always include? Reporting that quietly notes "the study was small" or "the effect was modest" is usually more trustworthy than reporting that promises a miracle.

One study is rarely the whole story

The most important habit of all is to resist building a belief on a single paper. Real confidence in science comes from replication — other teams running the study again and getting similar results — and from consensus, the broad agreement that builds up across many studies over time. A lone result that contradicts a large body of established evidence is far more likely to be the outlier than the breakthrough.

This is also why bodies like the NHS, the WHO and Cochrane base their guidance on the weight of all the evidence rather than the latest single headline. Solid findings tend to be confirmed and absorbed into that wider picture; fragile ones tend to fade. Giving any one study time to be tested by others is rarely a mistake.

A short checklist

Next time you meet a "study found" claim, you can run through a few quick questions:

  1. What kind of study is it — anecdote, observation, trial, or review?
  2. Is it claiming a link, or claiming a cause? Does the design support that?
  3. How many people were studied, and were they humans or animals?
  4. Has it been peer-reviewed, and where was it published?
  5. Who funded it, and are conflicts of interest declared?
  6. Is it a preprint, or a finished, reviewed paper?
  7. Does the headline match the study's actual, cautious wording?
  8. Do other studies agree, or does this one stand alone?

When a news story leans on "a study found", the real question is whether that study actually supports the claim being made. Our checker reads the article, weighs how its sources are used, and flags where a finding has been stretched.

Check an article

Related guides